Shop

Showing 46–54 of 1840 resultsSorted by latest

Temporary Moratorium on Agent and Broker Registration: Compliance Strategies for Federally-facilitated Exchanges
$129.99
DOE Final Rule: Electric Energy Export Authorization Compliance (10 CFR Part 205)
$49.99
Benchmark: FDA Proposed Rule: Nonclinical Testing Terminology Updates for Drug and Biologic Regulation
FDA Proposed Rule: Nonclinical Testing Terminology Updates for Drug and Biologic Regulation
$129.99
FDA Nonclinical Testing Terminology Rule: Key Regulatory Updates for Drug and Biologic Submissions
$49.99
Benchmark: Softwood Lumber Assessment Rate and Board Membership Rule Compliance
Softwood Lumber Assessment Rate and Board Membership Rule Compliance
$129.99
Employment in the Excepted Service: OPM’s Proposed Regulatory Amendments
$129.99
Benchmark: SEC Proposed Changes: Shareholder Proposal Regulation and Proxy Voting Updates

CourseAvenue eLearning Platform has helped Federal agencies (and their suppliers) successfully address their most complex eLearning accessibility challenges.

Contact CourseAvenue

QUICK LINKS

LATEST Products

FDA Compliance for High Throughput DNA Sequencing Cancer Test Systems

Oct 7, 2026

Why This Course is Important
Without this course, you risk overlooking critical FDA special controls, which can lead to device reclassification, legal penalties, and loss of market access for your hereditary cancer DNA sequencing products.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medical Devices; Immunology and Microbiology Devices; Classification of the High Throughput DNA Sequencing for Hereditary Cancer Predisposition Assessment Test System.

Key regulatory references include:

21 CFR Part 866 – Immunology and Microbiology Devices

Course SKU
FR-26-2250-1

FDA 510(k) Exemption for Class II Clinical Toxicology Test Systems: Compliance and Implementation

Oct 7, 2026

Why This Course is Important
Without this training, manufacturers and stakeholders risk failing to comply with the new exemption requirements, exposing their companies to enforcement actions, unnecessary 510(k) submissions, or loss of market access for clinical toxicology test systems.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medical Devices; Exemptions From Premarket Notification: Class II Devices; Certain Clinical Toxicology Test Systems.

Key regulatory references include:

21 CFR Part 862 – Clinical Chemistry and Clinical Toxicology Devices

Course SKU
FR-26-2249-1

Shop

Temporary Moratorium on Agent and Broker Registration: Compliance Strategies for Federally-facilitated Exchanges

DOE Final Rule: Electric Energy Export Authorization Compliance (10 CFR Part 205)

Benchmark: FDA Proposed Rule: Nonclinical Testing Terminology Updates for Drug and Biologic Regulation

FDA Proposed Rule: Nonclinical Testing Terminology Updates for Drug and Biologic Regulation

FDA Nonclinical Testing Terminology Rule: Key Regulatory Updates for Drug and Biologic Submissions

Benchmark: Softwood Lumber Assessment Rate and Board Membership Rule Compliance

Softwood Lumber Assessment Rate and Board Membership Rule Compliance

Employment in the Excepted Service: OPM’s Proposed Regulatory Amendments

Benchmark: SEC Proposed Changes: Shareholder Proposal Regulation and Proxy Voting Updates

QUICK LINKS

Course Catalog

Terms & Conditions

Accessibility

LATEST Products

FDA Compliance for High Throughput DNA Sequencing Cancer Test Systems

FDA 510(k) Exemption for Class II Clinical Toxicology Test Systems: Compliance and Implementation